CaltechTHESIS
  A Caltech Library Service

Advancing the Protein-Catalyzed Capture Agent Technology to New Frontiers

Citation

McCarthy, Amy Michelle (2018) Advancing the Protein-Catalyzed Capture Agent Technology to New Frontiers. Dissertation (Ph.D.), California Institute of Technology. doi:10.7907/HHP5-1Z83. https://resolver.caltech.edu/CaltechTHESIS:06012018-005336099

Abstract

Protein-catalyzed capture (PCC) agents are a nascent synthetic aptamer technology that was first disclosed in 2009. In addition to reviewing the different classes of peptide-based aptamers in chapter 1, this thesis records efforts to advance the PCC technology in two ways. First, in chapter 2 the development of a barcoded-rapid assay platform (B-RAP) technology enables the parallel analysis of up to fifteen PCC agents at once as well as dramatically shortening the time required to characterize the binding affinity for a pool of ligands from weeks to a couple of days. Secondly, the capture agent technology was utilized to target difficult proteins. Kirsten rat sarcoma (KRas) protein is a GTPase that acts as a light switch for several important cellular signaling pathways. Oncogenic variants of KRas are responsible for driving roughly 20-25% of all cancers, but KRas is considered “undruggable” from a small molecule targeting point of view. We report the identification of PCC ligands that bind to conserved allosteric switches on KRas and inhibit the protein’s GTPase enzymatic activity. The biomarker Plasmodium falciparum Histidine Rich Protein II (HRP2) presents an unusual challenge as it is a highly variable, unstructured and sticky protein. In chapter 3 we report on efforts to develop low nM binding capture agents against highly prevalent epitopes of HRP2, and the use of medicinal chemistry optimization to prepare structurally related variants of the lead capture agent for probing the structure-activity relationship and how it affects binding to HRP2.

Item Type:Thesis (Dissertation (Ph.D.))
Subject Keywords:Protein-catalyzed capture agents; rapid assay; malaria; KRas; DNA barcode; cysteine-modified streptavidin; PCC; allosteric inhibitor; GTPase
Degree Grantor:California Institute of Technology
Division:Chemistry and Chemical Engineering
Major Option:Chemistry
Thesis Availability:Public (worldwide access)
Research Advisor(s):
  • Heath, James R.
Thesis Committee:
  • Dougherty, Dennis A. (chair)
  • Peters, Jonas C.
  • Davis, Mark E.
  • Heath, James R.
Defense Date:21 May 2018
Record Number:CaltechTHESIS:06012018-005336099
Persistent URL:https://resolver.caltech.edu/CaltechTHESIS:06012018-005336099
DOI:10.7907/HHP5-1Z83
ORCID:
AuthorORCID
McCarthy, Amy Michelle0000-0003-3456-0383
Default Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:10993
Collection:CaltechTHESIS
Deposited By: Amy McCarthy
Deposited On:04 Jun 2018 19:48
Last Modified:25 May 2021 22:55

Thesis Files

[img]
Preview
PDF (Thesis File) - Final Version
See Usage Policy.

13MB
[img]
Preview
PDF (Chapter 1) - Final Version
See Usage Policy.

855kB
[img]
Preview
PDF (Chapter 2) - Final Version
See Usage Policy.

492kB
[img]
Preview
PDF (Appendix 2A-Materials and Methods for Chapter 2) - Final Version
See Usage Policy.

510kB
[img]
Preview
PDF (Appendix 2B-Supplementary Figures for Chapter 2) - Final Version
See Usage Policy.

3MB
[img]
Preview
PDF (Appendix 2C-Supplementary Tables for Chapter 2) - Final Version
See Usage Policy.

883kB
[img]
Preview
PDF (Chapter 3 plus Appendices 3A, 3B, 3C) - Final Version
See Usage Policy.

7MB

Repository Staff Only: item control page